Control of cytolocalization and mechanism of cell death by encapsulation of a photosensitizer

Journal of Biomedical Nanotechnology

Volumn 9, Issue 8, 2013, Pages 1307-1317

  Deda, Daiana K ^a   Pavani, Christiane ^a   Caritá, Eduardo ^a   Baptista, Maurício S ^a   Toma, Henrique E ^a   Araki, Koiti ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Apoptosis; Cytolocalization; Necrosis; Photodynamic therapy; Polymeric nanocapsules

Indexed keywords

ATELOCOLLAGEN; CELL NECROSIS; CYTOLOCALIZATION; CYTOPLASMIC MEMBRANE; NECROSIS; PHOTO-DAMAGE; PHOTODYNAMIC TREATMENTS; POLYMERIC NANOCAPSULES;

CELL DEATH; CELL MEMBRANES; NANOCAPSULES; PHOTODYNAMIC THERAPY;

PHOTOSENSITIZERS;

5,10,15 TRIPHENYL 20 (3 N METHYLPYRIDINIUM YL)PORPHYRIN; ATELOCOLLAGEN; NANOCAPSULE; PHOTOSENSITIZING AGENT; UNCLASSIFIED DRUG; XANTHAN;

APOPTOSIS; ARTICLE; CELLULAR DISTRIBUTION; ENCAPSULATION; HELA CELL; HUMAN; HUMAN CELL; LYSOSOME; MITOCHONDRION; NECROSIS; PHOTODYNAMIC THERAPY;

APOPTOSIS; BIOLOGICAL AVAILABILITY; DRUG CARRIERS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; HELA CELLS; HUMANS; MICROSCOPY, CONFOCAL; NANOCAPSULES; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; SIGNAL TRANSDUCTION;

EID: 84880900998     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2013.1614     Document Type: Article

References (58)

1. T. J. Dougherty, Photodynamic Therapy. Photochem. Photobiol. 58, 895 (1993).
2. S. K. Pushpan, S. Venkatraman, V. G. Anand, J. Sankar, D. Parmeswaran, S. Ganesan, and T. K. Chandrashekar, Porphyrins in photodynamic therapy-A search for ideal photosensitizers. Curr. Med. Chem.-Anti-Cancer Agents 2, 187 (2002).
3. R. R. Allison, H. C. Mota, V. S. Bagnato, and C. H. Sibata, Bionanotechnology and photodynamic therapy-State of the art review. Photodiagn. Photodyn. Ther. 5, 19 (2008).
4. S. I. Moriwaki, J. Misawa, Y. Yoshinari, I. Yamada, M. Takigawa, and Y. Tokura, Analysis of photosensitivity in Japanese cancerbearing patients receiving photodynamic therapy with porfimer sodium (Photofrin (TM)). Photodermatol. Photoimmunol. Photomed. 17, 241 (2001).
5. D. Bechet, P. Couleaud, C. Frochot, M. L. Viriot, F. Guillemin, and M. Barberi-Heyob, Nanoparticles as vehicles for delivery of photodynamic therapy agents. Trends Biotechnol. 26, 612 (2008).
6. V. Chaleix, V. Sol, and P. Krausz, Pseudo porphyrinyl amino acids based on 1,3,5-triazine scaffold: New tools for the synthesis of peptidic porphyrins. Tetrahedron Lett. 52, 2977 (2011).
7. C. Hopper, Photodynamic therapy: A clinical reality in the treatment of cancer. Lancet Oncology 1, 212 (2000).
8. E. Paszko, C. Ehrhardt, M. O. Senge, D. P. Kelleher, and J. V. Reynolds, Nanodrug applications in photodynamictherapy. Photodiagn. Photodyn. Ther. 8, 14 (2011).
9. V. V. Serra, A. Zamarron, M. A. F. Faustino, M. C. Iglesias-de la Cruz, A. Blazquez, J. M. M. Rodrigues, M. Neves, J. A. S. Cavaleiro, A. Juarranz, and F. Sanz-Rodriguez, New porphyrin amino acid conjugates: Synthesis and photodynamic effect in human epithelial cells. Bioorg. Med. Chem. 18, 6170 (2010).
10. S. Sharma and M. Nath, Novel 5-benzazolyl-10,15,20-triphenylporphyrins and beta, meso-benzoxazolyl-bridged porphyrin dyads: Synthesis, characterization and photophysical properties. Dyes Pigm. 92, 1241 (2012).
11. K. Araki, F. M. Engelmann, I. Mayer, H. E. Toma, M. S. Baptista, H. Maeda, A. Osuka, and H. Furuta, Doubly N-confused porphyrins as efficient sensitizers for singlet oxygen generation. Chem. Lett. 32, 244 (2003).
12. M. Triesscheijn, P. Baas, J. H. M. Schellens, and F. A. Stewart, Photodynamic therapy in oncology. Oncologist 11, 1034 (2006).
13. A. F. Uchoa, C. S. Oliveira, and M. S. Baptista, Relationship between structure and photoactivity of porphyrins derived from protoporphyrin IX. J. Porph. Phthalocyan. 14, 832 (2010).
14. Y. M. Zheng, K. Wang, T. Li, X. L. Zhang, and Z. Y. Li, Synthesis, singlet oxygen photogeneration and dna photocleavage of porphyrins with nitrogen heterocycle tails. Molecules 16, 3488 (2011).
15. W. H. Lei, J. F. Xie, Y. J. Hou, G. Y. Jiang, H. Y. Zhang, P. F. Wang, X. S. Wang, and B. W. Zhang, Mitochondria-targeting properties and photodynamic activities of porphyrin derivatives bearing cationic pendant. J. Photochem. Photobiol. B 98, 167 (2010).
16. N. L. Oleinick, R. L. Morris, and T. Belichenko, The role of apoptosis in response to photodynamic therapy: What, where, why, and how. Photochem. Photobiol. Sci. 1, 1 (2002).
17. C. S. Oliveira, R. Turchiello, A. J. Kowaltowski, G. L. Indig, and M. S. Baptista, Major determinants of photoinduced cell death: Subcellular localization versus photosensitization efficiency. Free Radical. Bio. Med. 51, 824 (2011).
18. D. Kessel, M. Antoiovich, and K. M. Smith, The role of the peripheral benzodiazepine receptor in the apoptotic response to photodynamic therapy. Photochem. Photobiol. 74, 346 (2001).
19. D. Kessel and N. Oleinick, Initiation of autophagy by photodynamic therapy. Methods Enzymol. 453, 1 (2009).
20. D. Kessel, Y. Luo, P. Mathieu, and J. Reiners, Jr, Determinants of the apoptotic response to lysosomal photodamage. Photochem. Photobiol. 71, 196 (2000).
21. J. Y. Chen, N. H. Cheung, M. C. Fung, J. M. Wen, W. N. Leung, and N. K. Mak, Subcellular localization of merocyanine 540 (MC540) and induction of apoptosis in murine myeloid leukemia cells. Photochem. Photobiol. 72, 114 (2000).
22. D. Kessel and Y. Luo, Mitochondrial photodamage and PDT-induced apoptosis. J. Photochem. Photobiol. B 42, 89 (1998).
23. D. Kessel and Y. Luo, Photodynamic therapy: A mitochondrial inducer of apoptosis. Cell Death Differ. 6, 28 (1999).
24. D. Kessel, Y. Luo, Y. Q. Deng, and C. K. Chang, The role of subcellular localization in initiation of apoptosis by photodynamic therapy. Photochem. Photobiol. 65, 422 (1997).
25. A. T. Hoye, J. E. Davoren, P. Wipf, M. P. Fink, and V. E. Kagan, Targeting mitochondria. Accounts Chem. Res. 41, 87 (2008).
26. F. M. Engelmann, I. Mayer, D. S. Gabrielli, H. E. Toma, A. J. Kowaltowski, K. Araki, and M. S. Baptista, Interaction of cationic meso-porphyrins with liposomes, mitochondria and erythrocytes. J. Bioenerg. Biomembr. 39, 175 (2007).
27. F. M. Engelmann, S. V. O. Rocha, H. E. Toma, K. Araki, and M. S. Baptista, Determination of n-octanol/water partition and membrane binding of cationic porphyrins. Int. J. Pharm. 329, 12 (2007).
28. E. Reddi, Role of delivery vehicles for photosensitizers in the photodynamic therapy of tumours. J. Photochem. Photobiol. B 37, 189 (1997).
29. V. P. Torchilin, Multifunctional nanocarriers. Adv. Drug Delivery Rev. 58, 1532 (2006).
30. C. Kojima, Y. Toi, A. Harada, and K. Kono, Preparation of poly(ethylene glycol)-attached dendrimers encapsulating photosensitizers for application to photodynamic therapy. Bioconjugate Chem. 18, 663 (2007).
31. A. B. Solovieva, N. S. Melik-Nubarov, T. M. Zhiyentayev, P. I. Tolstih, I. I. Kuleshov, N. A. Aksenova, E. A. Litmanovich, N. N. Glagolev, V. A. Timofeeva, and A. V. Ivanov, Development of novel formulations for photodynamic therapy on the basis of amphiphilic polymers and porphyrin photosensitizers, pluronic influence on photocatalytic activity of porphyrins. Laser Phys. 19, 817 (2009).
32. A. Mazzaglia, N. Micali, L. M. Scolaro, M. T. Sciortino, S. Sortino, and V. Villari, Design of photosensitizer/cyclodextrin nanoassemblies: spectroscopy, intracellular delivery and photodamage. J. Porph. Phthalocyan. 14, 661 (2010).
33. D. Q. Wu, Z. Y. Li, C. Li, J. J. Fan, B. Lu, C. Chang, S. X. Cheng, X. Z. Zhang, and R. X. Zhuo, Porphyrin and galactosyl conjugated micelles for targeting photodynamic therapy. Pharm. Res. 27, 187 (2010).
34. S. Ballut, D. Naud-Martin, B. Loock, and P. Maillard, A Strategy for the targeting of photosensitizers, synthesis, characterization, and photobiological property of porphyrins bearing glycodendrimeric moieties. J. Org. Chem. 76, 2010 (2011).
35. D. K. Chatterjee, L. S. Fong, and Y. Zhang, Nanoparticles in photodynamic therapy: An emerging paradigm. Adv. Drug Delivery Rev. 60, 1627 (2008).
36. M. Lilletvedt, G. Smistad, H. H. Tonnesen, A. Hogset, and S. Kristensen, Solubilization of the novel anionic amphiphilic photosensitizer TPCS(2a) by nonionic pluronic block copolymers. Eur. J. Pharm. Sci. 43, 180 (2011).
37. E. K. Oh, S. E. Jin, J. K. Kim, J. S. Park, Y. Park, and C. K. Kim, Retained topical delivery of 5-aminolevulinic acid using cationic ultradeformable liposomes for photodynamic therapy. Eur. J. Pharm. Sci. 44, 149 (2011).
38. P. R. Silva, L. L. R. Vono, B. P. Esposito, M. S. Baptista, and L. M. Rossi, Enhancement of hematoporphyrin IX potential for photodynamic therapy by entrapment in silica nanospheres. Phys. Chem. Chem. Phys. 13, 14946 (2011).
39. R. Rychtarikova, S. Sabata, J. Hetflejs, and G. Kuncova, Photodynamic efficiency of porphyrins encapsulated in polysilsesquioxanes. Chem. Pap. 66, 269 (2012).
40. D. K. Deda, A. F. Uchoa, E. Carita, M. S. Baptista, H. E. Toma, and K. Araki, A new micro/nanoencapsulated porphyrin formulation for PDT treatment. Int. J. Pharm. 376, 76 (2009).
41. W. Jiang, B. Y. S. Kim, J. T. Rutka, and W. C. W. Chan, Nanoparticle-mediated cellular response is size-dependent. Nat. Nanotechnol. 3, 145 (2008).
42. Y. S. Lee, D. W. Kim, Y. H. Lee, J. H. Oh, S. Yoon, M. S. Choi, S. K. Lee, J. W. Kim, K. Lee, and C.-W. Song, Silver nanoparticles induce apoptosis and G2/M arrest via PKCf-dependent signaling in A549 lung cells. Arch. Toxicol. 85, 1529 (2011).
43. J. J. Li, D. Hartono, C.-N. Ong, B.-H. Bay, and L.-Y. L. Yung, Autophagy and oxidative stress associated with gold nanoparticles. Biomaterials 31, 5996 (2010).
44. F. M. Menger and B. M. Sykes, Anatomy of a coacervate. Langmuir 14, 4131 (1998).
45. F. M. Engelmann, P. Losco, H. Winnischofer, K. Araki, and H. E. Toma, Synthesis, electrochemistry, spectroscopy and photophysical properties of a series of meso-phenylpyridylporphyrins with one to four pyridyl rings coordinated to [Ru(bipy)2Cl]+groups. J. Porphyr. Phthalocya. 6, 33 (2002).
46. D. K. Deda, C. Pavani, E. Carita, M. S. Baptista, H. E. Toma, and K. Araki, Correlation of photodynamic activity and singlet oxygen quantum yields in two series of hydrophobic monocationic porphyrins. J. Porph. Phthalocyan. 16, 56 (2012).
47. F. Sauzedde, F. Ganachaud, A. Elaissari, and C. Pichot, Emulsifierfree emulsion copolymerization of styrene with two different aminocontaining monomers 2, surface and colloidal characterization. J. Appl. Polym. Sci. 65, 2331 (1997).
48. I. Vermes, C. Haanen, and C. Reutelingsperger, Flow cytometry of apoptotic cell death. J. Immunol. Methods 243, 167 (2000).
49. M. D. Klaus, Apoptosis pathways in cancer and cancer therapy. Cancer Immunol. Immunother. 53, 153 (2004).
50. B. R. You and W. H. Park, The enhancement of propyl gallate-induced HeLa cell death by MAPK inhibitors is accompanied by increasing ROS levels. Mol. Biol. Rep. 38, 2349 (2011).
51. P. Bernardi, L. Scorrano, R. Colonna, V. Petronilli, and F. Di Lisa, Mitochondria and cell death-Mechanistic aspects and methodological issues. Eur. J. Biochem. 264, 687 (1999).
52. D. Ren, G. Peng, H. Huang, H. Wang, and S. Zhang, Effect of rhodoxanthin from potamogeton crispus L. on cell apoptosis in Hela cells. Toxicol. In Vitro 20, 1411 (2006).
53. M. P. Denofrio, C. Lorente, T. Breitenbach, S. Hatz, F. M. Cabrerizo, A. H. Thomas, and P. R. Ogilby, Photodynamic effects of pterin on hela cells. Photochem. Photobiol. 87, 862 (2011).
54. N. J. Waterhouse and J. A. Trapani, A new quantitative assay for cytochrome c release in apoptotic cells. Cell Death Differ. 10, 853 (2003).
55. L. Baruch and M. Machluf, Alginate-chitosan complex coacervation for cell encapsulation: Effect on mechanical properties and on longterm viability. Biopolymers 82, 570 (2006).
56. E. Buytaert, M. Dewaele, and P. Agostinis, Molecular effectors of multiple cell death pathways initiated by photodynamic therapy. Bba-Rev. Cancer 1776, 86 (2007).
57. J. Kralova, T. Briza, I. Moserova, B. Dolensky, P. Vasek, P. Pouckova, Z. Kejik, R. Kaplanek, P. Martasek, M. Dvorak, and V. Kral, Glycol porphyrin derivatives as potent photodynamic inducers of apoptosis in tumor cells. J. Med. Chem. 51, 5964 (2008).
58. D. Kessel, M. Castelli, and J. J. Reiners, Apoptotic response to photodynamic therapy versus the Bcl-2 antagonist HA14-1. Photochem. Photobiol. 76, 314 (2002).